Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: VANI) | Delayed: 1.08 -0.01 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $ | |||
| Open | $1.08 | 52 Week Low | $ | |||
| Day High | $1.09 | P/E | N/A | |||
| Day Low | $1.08 | EPS | $ | |||
| Volume | 16,924 | |||||
